371 a Acne Excoriee , 21, 22 Acneiform Disorders , 340 Acne

371 a Acne Excoriee , 21, 22 Acneiform Disorders , 340 Acne

Index A African American community Acne excoriee , 21, 22 cocoa butter , 302 Acneiform disorders , 340 diagnosis codes, dermatologist Acne keloidalis nuchae (AKN) , 340 visit , 301 description , 130 hair myths , 303 diagnosis , 131, 132 patient care , 304 differential diagnosis , 133 skin myths , 301–303 epidemiology , 130–131 African descent, cultural considerations histopathology , 133 description , 300 laser hair removal , 244 health services utilization , 300–301 pathogenesis , 131 misconceptions , 301 prevalence , 130–131 AGA. See Androgenetic alopecia (AGA) treatment Aging effects, ethnic skin , 248–249 fi rst line therapy , 134–135 AKN. See Acne keloidalis nuchae (AKN) minimally invasive therapy , 135 Alaluf, S. , 6 surgical , 135 Alexis, A.F. , 23 Acne vulgaris (AV) Alopecia areata , 99–100 aggravating factors , 23 Alopecia syphilitica , 101–102 clinical features , 21–23 Alpha hydroxy acids , 286–288 epidemiology , 23–24 Alster, T. , 197 management Anagen ef fl uvium (AE) , 99 oral therapy , 27 Androgenetic alopecia (AGA) , 97–98, procedural therapy , 27–28 355–356 topical therapy , 24–26 Antimalarials pathogenic factors , 23 lupus erythematosus , 55 PIH , 22 sarcoidosis , 71 vs. rosacea , 29 Aramaki, J. , 10 sequelae , 28 Aromatherapy, traditional Asian practice Acupuncture alopecia areata , 309 traditional Asian practice, cutaneous contact dermatitis , 309, 310 conditions description , 307 adverse effects , 311 phototoxic reaction , 309 description , 309 Ashy dermatosis. See Erythema evaluation process , 310 dyschromicum perstans (EDP) psoriasis , 310 Asian skin Adrian, R.M. , 229 irritants and allergens , 40 AE. See Anagen ef fl uvium (AE) structure and physiology , 39 A.F. Alexis and V.H. Barbosa (eds.), Skin of Color: A Practical Guide 371 to Dermatologic Diagnosis and Treatment, DOI 10.1007/978-0-387-84929-4, © Springer Science+Business Media New York 2012 372 Index Atopic dermatitis (AD) cosmetic applications , 265 characterization , 45 cosmetic procedure , 263 differential diagnosis , 48 description , 263 distribution and morphology , 45, 46 dynamic wrinkles , 272–273 epidemiology , 47 facial shaping, dermal fi llers , 260–261 feature , 45, 46 history , 265 histopathology , 47 injection technique , 267–268 incidence , 47 photoaging , 232–233 laboratory fi ndings , 47 pre and postoperative care , 266 pathophysiology , 47 serotypes , 263 pediatric diseases, children of color side effects , 272 criteria , 332 treatment guidelines Dennie-Morgan folds , 332, 333 axillary hyperhidrosis , 271 differential diagnosis , 335, 336 bunny lines , 269, 270 features , 331 chin lines , 270, 271 licheni fi cation , 332, 333 Crow’s feet , 269, 270 lichenoid , 333 eyelid ptosis , 271 skin care , 334–335 forehead lines , 269 treatment , 333 Glabellar lines , 268 therapy , 48, 49 lateral browlift , 269 Autoimmune diseases Marionette lines , 269–270 alopecia areata , 99 Botwood, N. , 198 children of color , 347 Bowen’s disease , 215 Autologous minigraft technique , 174 Brown, D.L. , 80 Autologous thin Thiersch graft technique , 174 Bulengo-Ransby, S. , 149 AV. See Acne vulgaris (AV) Busquets, A. , 201 B C Bacterial-derived hyaluronic acid , 251 Canella, A. , 277 Ballow, M. , 46, 48 CCCA. See Central centrifugal cicatricial Basal cell carcinoma (BCC) alopecia (CCCA) atypical presentation , 212 Cell layers , 5 differential diagnosis , 213, 214 Central centrifugal cicatricial alopecia nodular-pigmented , 213 (CCCA) Battle, E.F., Jr. , 240 clinical features , 107–108 Bayat, A. , 189 epidemiology , 107 Berardesca, E. , 4, 9, 10 etiology , 107 Berman, B. , 200, 201 features , 106, 107 Berman, N. , 200 hair transplants, ethnic populations , Bernard, B.A. , 7 358–359 Beta hydroxy acid , 288–289 previous names , 106 Black skin treatment , 108–109 irritants and allergens , 40 Chan, L.S. , 46, 49 structure and physiology , 39 Chan, R. , 143 Bleomycin , 204 Chemical peels Botulinum toxin A (BtxA) bene fi ts , 283, 286 action mechanism , 266 description , 280 aging process , 264–265 peeling agents, classi fi cation of , 280 Botox vs. Dysport , 263, 264 risks , 280, 283 clinical use , 265 Child, F.J. , 24 commercial preparations , 266 Children of color complications , 272 autoimmune diseases , 347 contraindications , 267 description , 327 Index 373 genetic disorders , 347 Corneocyte variability , 5 in fl ammatory diseases , 345–346 Corticosteroids metabolic syndrome , 346–347 acne keloidalis nuchae , 134–135 pediatric diseases keloids atopic dermatitis , 331–336 polytherapy , 192 con fl uent and reticulated side effects , 192–193 papillomatosis , 339 solo therapy , 190–192 follicular disorders , 339–343 uses of , 190 nickel allergic contact dermatitis , 338 pityriasis alba , 164 pigmentary disorders , 343–345 sarcoidosis , 70 pityriasis rosea , 337 Cosman, B. , 182 psoriasis , 338 Cosmetic concerns seborrheic dermatitis , 337 advantages , 222 pigmentary alteration causes , 327–329 disadvantages , 222 skin development DPN , 228, 229 linear pigmentation , 330, 331 hyperpigmentation melanocyte migration , 329–330 description , 222 melanosomes , 329 diffuse , 224 Mongolian spots , 330 facial , 223 transient neonatal pustular melanosis , localized , 223–224 330 treatment therapies , 225–226 Voight/Futcher’s lines , 331 keloids , 227–228 Choi, S. , 225 skin laxity Chronic cutaneous lupus erythematosus , description , 231 115, 116 infrared tightening , 231–232 Chua, S.H. , 231 radiofrequency (RF) , 231 Chuangsuwanich, A. , 201 unwanted hair removal Cicatricial alopecias diode laser , 229 lymphocytic Nd:YAG system , 230–231 CCCA , 106–109 topical e fl ornithine HCl , 228 chronic cutaneous lupus erythematosus , Crespo-Erchiga, V. , 83 115, 116 Cupping technique , 311–312 LPP , 110–114 Cutaneous needle , 309 neutrophilic DCS , 116–118 FD , 118–119 D North American Hair Research Society DCS. See Dissecting cellulitis of the (NAHRS) classi fi cation , 106 scalp (DCS) Classic lichen planopilaris (LPP) , 110–111 Deep chemical peels , 296 Clostridium botulinum , 263 Dermal-epidermal junction (DEJ) , 3 Coin rubbing/coining technique , 311 Dermal fi llers, ethnic skin Comedone extraction, acne vulgaris , 27 aging effects , 248–249 Conejo-Mir, J.S. , 197 cosmetic products growth , 247 Con fl uent and reticulated PLLA , 255–261 papillomatosis , 339 soft tissue augmentation , 250–255 Contact dermatitis Dermal structure , 7–8 allergens , 41–42 Dermatosis papulosa nigra (DPN) , 228, 229 clinical presentation , 39 Dermis , 3 description , 37 De Winter, S. , 7, 11 epidemiology , 37–38 Diffuse hyperpigmentation , 224 patch testing , 41–42 Discoid lupus erythematosus (DLE) , Corcuff, P. , 5 115, 116 374 Index Disorders of hyperpigmentation Erythematotelangiectatic rosacea (ETR) , 29–30 melasma Espana, A. , 204 cheeks/nose/forehead , 140 clinical diagnosis , 140–141 clinical recommendations , 146–147 F description , 139 Fabbri, P. , 56 etiology , 140 Facial lipoatrophy histologic patterns , 141 grading scale , 256, 257 laser and light therapy , 144–146 injection technique , 257 peeling agents , 143–144 safety and ef fi cacy history , 256–257 topical agents , 141–143 treatment sessions , 257 US preventive services task force grade Faergemann, J. , 78 de fi nitions , 146, 148 Falabella, R. , 163 nevus of Ito , 151–154 Farber, E.M. , 60 nevus of Ota FD. See Folliculitis decalvans (FD) classi fi cation , 153 Fernandez-Faith, E. , 65, 66, 70 clinical diagnosis , 152–153 Fibrosing Alopecia in a Pattern Distribution clinical recommendations , 154 (FAPD) , 111, 112 description , 151 Filiform steel needle , 309 etiology , 152 Fitzpatrick, R. , 202, 203, 228 histopathology , 153 5- fl uorouracil (5-FU) , 202–203 Q-switched laser therapy , 154 Florencio, V.D. , 83 periorbital hypermelanosis Flores, F. , 200 clinical diagnosis , 155 Flores-Hughes, G. , 319 description , 155 Follicular disorders , 339–343 etiology , 155 Folliculitis decalvans (FD) , 118–119 histopathology , 155 Foot corrections , 258–259 recommendations , 156 Fox , 280 treatment , 155–156 Fox, H. , 163 PIH Foy, V. , 10 clinical diagnosis , 148, 149 Frank, J.E. , 80 clinical recommendations , 150–151 Frontal fi brosing alopecia (FFA) , 111 description , 148 etiology , 148 histopathology , 148–149 G peeling agents , 150 Galadari, I. , 240 topical agents , 149–150 Garg, V.K. , 144, 150 Dissecting cellulitis of the scalp (DCS) , 116–118 Genetic disorders , 347 DLE. See Discoid lupus erythematosus (DLE) George, A.O. , 131 DPN. See Dermatosis papulosa nigra (DPN) González, L.M. , 57, 59 Dreschnack, P. , 256 Gottlieb, A.B. , 63, 64 Duncan, M. , 200 Grabski, W. , 196 Durani, P. , 189 Graham Little syndrome , 112 Granstein, R. , 200 Grant-Kels, J.M. , 332 E Granulomatous rosacea , 30 Earles, R.M. , 355 Grif fi th, B. , 191 Earlobe keloids , 194–197 Grimes, P.E. , 142, 222, 289 Ear needle , 309 Grooming-induced alopecias , 91–92 Ellgehausen, P. , 51 Guerra, L. , 171 Epidermis , 3 Gunjittisomram, S. , 201 Erythema dyschromicum perstans (EDP) , 344 Gupta, A.K. , 78, 83 Index 375 Gupta, S. , 202 mestizo , 320 Guy, R.H. , 9 mulattos , 320 personalism , 321 terminology , 319 H HMF. See Hypopigmented mycosis fungoides Hair characteristics (HMF) African ancestry , 351, 352 Hobbs, L.M. , 240 Asian populations , 351, 352 Hochberg, M.C. , 52 Caucasians , 351, 352 Hyaluronic acid, soft tissue augmentation curved hair follicle , 352 bacterial-derived , 251 racial/ethnic populations , 353 description , 250–251 Hair myths, African American community , enhancement precautions , 251, 253 303 overview , 251, 252 Hair transplantation, ethnic populations viscoelastic

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    12 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us